Login to Your Account

Scioderm seeks fast track with breakthrough drug for rare skin disorder

By Jennifer Boggs
Managing Editor

Friday, April 18, 2014

"The worst disease you've never heard of." That's how patient advocacy and nonprofit group Debra (Dystrophic Epidermolysis Bullosa Research Association of America) refer to epidermolysis bullosa (EB), a rare genetic disorder characterized by fragile skin that it often leaves its sufferers with chronic open wounds and blisters.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription